17.01.2013 Views

section 1 - World Intellectual Property Organization

section 1 - World Intellectual Property Organization

section 1 - World Intellectual Property Organization

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

37/2000<br />

13238 PCT Gazette - Section I - Gazette du PCT 14 Sep/sep 2000<br />

(54) N–PROTECTED SYNTHESIS ME-<br />

THOD FOR USE IN MAKING POR-<br />

PHYRINS<br />

SYNTHESE N–PROTEGEE CON-<br />

VENANT A LA PREPARATION DE<br />

PORPHYRINES<br />

(71) EMORY UNIVERSITY [US/US]; 2009<br />

Ridgewood Drive, Atlanta, GA 30322 (US).<br />

(72) NICKEL, Eric, G.; 8356–I Roswell Road,<br />

Atlanta, GA 30350 (US). LIEBESKIND,<br />

Lanny, S.; 2573 Kings Lake Court, Atlanta,<br />

GA 30345 (US).<br />

(74) JOHNSON, William, R. et al. / etc.;<br />

Needle & Rosenberg, P.C., 127 Peachtree<br />

Street, N.E., Suite 1200, Atlanta, GA 30303<br />

(US).<br />

(81) AU CA JP; EP (AT BE CH CY DE DK ES<br />

FI FR GB GR IE IT LU MC NL PT SE).<br />

(51) 7 C07D 207/38, 309/32, A61K 31/40,<br />

31/365, 31/38, 31/35, C07D 307/66,<br />

333/36, A61P 35/00<br />

(11) WO 00/53581 (13) A2<br />

(21) PCT/EP00/01721<br />

(22) 1 Mar/mar 2000 (01.03.2000)<br />

(25) en (26) en<br />

(30) MI99A000456 5 Mar/mar 1999<br />

(05.03.1999)<br />

(43) 14 Sep/sep 2000 (14.09.2000)<br />

(54) HETEROCYCLIC COMPOUNDS HA-<br />

VING ANTITUMOR ACTIVITY<br />

COMPOSES HETEROCYCLIQUES<br />

AYANT UNE ACTIVITE ANTITUMO-<br />

RALE<br />

(71) NOVUSPHARMA S.P.A. [IT/IT]; Piazza<br />

Durante, 11, I–20131 Milano (IT).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) MENTA, Ernesto [IT/IT]; (IT).<br />

CONTI, Marco [IT/IT]; (IT). PESCALLI,<br />

Nicoletta [IT/IT]; Via G.B. Stucchi, 110,<br />

I–20052 Monza (IT).<br />

(74) MINOJA, Fabrizio et al. / etc.; Bianchetti<br />

Bracco Minoja S.r.l., Via Rossini, 8, I–20122<br />

Milano (IT).<br />

(81) AE AL AM AT AU AZ BA BB BG BR BY<br />

CA CH CN CR CU CZ DE DK DM EE ES<br />

FI GB GD GE GH GM HR HU ID IL IN<br />

IS JP KE KG KP KR KZ LC LK LR LS LT<br />

LU LV MA MD MG MK MN MW MX NO<br />

NZ PL PT RO RU SD SE SG SI SK SL TJ<br />

TM TR TT TZ UA UG US UZ VN YU ZA<br />

ZW; AP (GH GM KE LS MW SD SL SZ<br />

TZ UG ZW); EA (AM AZ BY KG KZ MD<br />

RU TJ TM); EP (AT BE CH CY DE DK ES<br />

FI FR GB GR IE IT LU MC NL PT SE);<br />

OA (BF BJ CF CG CI CM GA GN GW ML<br />

MR NE SN TD TG).<br />

(51) 7 C07D 213/73, 417/06, 401/06, 413/06,<br />

233/88, A61K 31/44, 31/4439, 31/444,<br />

31/506, 31/501, 31/5355, 31/427, 31/4168,<br />

A91P 43/00, 25/28<br />

(11) WO 00/53582 (13) A1<br />

(21) PCT/JP00/01190<br />

IT<br />

(22) 1 Mar/mar 2000 (01.03.2000)<br />

(25) ja (26) ja<br />

(30) 11/57993 5 Mar/mar 1999<br />

(05.03.1999)<br />

(43) 14 Sep/sep 2000 (14.09.2000)<br />

(54) HETEROCYCLIC COMPOUNDS HA-<br />

VING EFFECT OF ACTIVATING<br />

NICOTINIC ACETYLCHOLINE<br />

RECEPTOR<br />

4 2<br />

COMPOSES HETEROCYCLIQUES<br />

POSSEDANT UN EFFET<br />

D’ACTIVATION DU RECEPTEUR<br />

4 2 DE L’ACETYLCHOLINE<br />

NICOTINIQUE<br />

(71) SUNTORY LIMITED [JP/JP]; 1–40, Dojimahama<br />

2–chome,<br />

Osaka 530–8203 (JP).<br />

Kita–ku, Osaka–shi,<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) IMOTO, Masahiro [JP/JP];<br />

11–96–401, Ootani–cho, Nishinomiya–shi,<br />

Hyogo 662–0054 (JP). IWANAMI, Tatsuya<br />

[JP/JP]; 34–2–903, Yahata–cho 2–chome,<br />

Ashikaga–shi, Tochigi 326–0824 (JP). AKA-<br />

BANE, Minako [JP/JP]; 1–37–201, Sojiji<br />

1–chome, Ibaraki–shi, Osaka 567–0801<br />

(JP). TANI, Yoshihiro [JP/JP]; 9–38, Hoshimi–cho,<br />

(JP).<br />

Ibaraki–shi, Osaka 567–0843<br />

(74) KUSAMA, Osamu; Kusama Patent Office,<br />

7f Iwata Bldg., 5–12, Iidabashi 4–chome,<br />

Chiyoda–ku, Tokyo 102–0072 (JP).<br />

(81) AU CA CN JP KR US; EP (AT BE CH CY<br />

DE DK ES FI FR GB GR IE IT LU MC NL<br />

PT SE).<br />

(51) 7 C07D 237/22, C07K 5/06, C07D 257/04,<br />

405/12, 261/12, 213/81, 237/06, 207/26,<br />

213/82, 307/68, A61K 31/165, 31/42, 31/44<br />

(11) WO 00/53583<br />

(21) PCT/US00/06022<br />

(13) A1<br />

(22) 9 Mar/mar 2000 (09.03.2000)<br />

(25) en (26) en<br />

(30) 09/265,410 10 Mar/mar 1999<br />

(10.03.1999)<br />

US<br />

(43) 14 Sep/sep 2000 (14.09.2000)<br />

(54) INHIBITORS OF PROTEIN TYROSINE<br />

PHOSPHATASE<br />

INHIBITEURS DE LA TYROSINE<br />

PHOSPHATASE<br />

(71) PHARMACIA & UPJOHN AB [SE/SE];<br />

S–112 87 Stockholm (SE).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) LARSEN, Scott, D. [US/US]; 56 Naples<br />

Court, Kalamazoo, MI 49009 (US). MAY,<br />

Paul, D. [US/US]; 7890 North 32nd Street,<br />

Richland, MI 49083 (US). BLEASDALE,<br />

John, E. [GB/US]; 3230 Lites End Court,<br />

Portage, MI 49024 (US). LILJEBRIS,<br />

Charlotta [SE/SE]; S–741 92 Knivsta (SE).<br />

SCHOSTAREZ, Heinrich, Josef [US/US];<br />

3236 Lost Pine Way, Portage, MI 49024<br />

(US). BARF, Tjeerd [NL/SE]; S–753<br />

34 Uppsala (SE). NILSSON, Marianne<br />

[SE/SE]; S–762 94 Rimbo (SE).<br />

JP<br />

(74) MURPHY, Gerald, M.; Birch, Stewart,<br />

Kolasch & Birch, L.L.P., P.O. Box 747, Falls<br />

Church, VA 22040–0747 (US).<br />

(81) AE AL AM AT AU AZ BA BB BG BR BY<br />

CA CH CN CR CU CZ DE DK DM EE ES<br />

FI GB GD GE GH GM HR HU ID IL IN<br />

IS JP KE KG KP KR KZ LC LK LR LS LT<br />

LU LV MA MD MG MK MN MW MX NO<br />

NZ PL PT RO RU SD SE SG SI SK SL TJ<br />

TM TR TT TZ UA UG US UZ VN YU ZA<br />

ZW; AP (GH GM KE LS MW SD SL SZ<br />

TZ UG ZW); EA (AM AZ BY KG KZ MD<br />

RU TJ TM); EP (AT BE CH CY DE DK ES<br />

FI FR GB GR IE IT LU MC NL PT SE);<br />

OA (BF BJ CF CG CI CM GA GN GW ML<br />

MR NE SN TD TG).<br />

Published / Publiée :(c)<br />

(51) 7 C07D 239/96<br />

(11) WO 00/53584 (13) A1<br />

(21) PCT/JP00/01360<br />

(22) 6 Mar/mar 2000 (06.03.2000)<br />

(25) ja (26) ja<br />

(30) 11/61390 9 Mar/mar 1999 JP<br />

(09.03.1999)<br />

(43) 14 Sep/sep 2000 (14.09.2000)<br />

(54) PROCESS FOR PRODUCING QUINA-<br />

ZOLINE DERIVATIVE OR SALT THE-<br />

REOF<br />

PROCEDE DE PRODUCTION D’UN<br />

DERIVE QUINAZOLINE OU D’UN<br />

SEL DE CE DERIVE<br />

(71) FUJISAWA PHARMACEUTICAL CO.,<br />

LTD. [JP/JP]; 4–7, Doshomachi 3–chome,<br />

Chuo–ku, Osaka–shi, Osaka 541–8514 (JP).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) FUKAGAWA, Masayasu [JP/JP]; 48,<br />

Jinden, Kamiichimachi, Nakaniikawa–gun,<br />

Toyama 930–0365 (JP). IEDA, Shigeru<br />

[JP/JP]; 5–1–1, Mukogaoka, Sanda–shi,<br />

Hyogo 669–1544 (JP). TSUBOI, Hiroyuki<br />

[JP/JP]; 19–1, Ishizuminamimachi, Neyagawa–shi,<br />

Osaka 572–0024 (JP). GOTO,<br />

Shunsuke [JP/JP]; 5–5–35–701, Nankounaka,<br />

Suminoe–ku, Osaka–shi, Osaka<br />

559–0033 (JP). KAGARA, Kooji [JP/JP];<br />

17–12, Onoharanishi 3–chome, Mino–shi,<br />

Osaka 562–0032 (JP). UEMATSU, Ryoichi<br />

[JP/JP]; 2–62–107, Takamatsu–cho,<br />

Takarazuka–shi, Hyogo 665–0043 (JP).<br />

NISIWAKI, Masanori [JP/JP]; 38–17,<br />

Hashimotonishikarimata, Yawata–shi, Kyoto<br />

614–8334 (JP).<br />

(74) TABUSHI, Eiji; Fujisawa Pharmaceutical<br />

Co., Ltd.Osaka Factory, 1–6, Kashima<br />

2–chome, Yodogawa–ku, Osaka–shi, Osaka<br />

532–8514 (JP).<br />

(81) AE AL AM AT AU AZ BA BB BG BR BY<br />

CA CH CN CU CZ DE DK EE ES FI GB<br />

GD GE GH GM HR HU ID IL IN IS JP KE<br />

KG KR KZ LC LK LR LS LT LU LV MD<br />

MG MK MN MW MX NO NZ PL PT RO<br />

RU SD SE SG SI SK SL TJ TM TR TT UA<br />

UG US UZ VN YU ZA ZW; AP (GH GM<br />

KE LS MW SD SL SZ TZ UG ZW); EA<br />

(AM AZ BY KG KZ MD RU TJ TM); EP<br />

(ATBECHCYDEDKESFIFRGBGR<br />

IE IT LU MC NL PT SE); OA (BF BJ CF<br />

CG CI CM GA GN GW ML MR NE SN TD<br />

TG).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!